NCOA-RET fusion as a secondary resistance mechanism to osimertinib in complex EGFR-mutated lung adenocarcinoma: Case report and review of literature

Alberto P. Romagnolo; Christopher Hino; Saied Mirshahidi; Kristina Chase; Hamid Mirshahidi

doi:10.1016/j.cpccr.2023.100232

NCOA-RET fusion as a secondary resistance mechanism to osimertinib in complex EGFR-mutated lung adenocarcinoma: Case report and review of literature

Alberto P. Romagnolo, Christopher Hino, Saied Mirshahidi, Kristina Chase, Hamid Mirshahidi

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	100232
Journal	Current Problems in Cancer: Case Reports
Volume	10
DOIs	https://doi.org/10.1016/j.cpccr.2023.100232
State	Published - Jun 2023

ASJC Scopus Subject Areas

Oncology

Keywords

Drug-resistance
EGFR-TKI
NSCLC
Osimertinib
RET fusion

Access to Document

10.1016/j.cpccr.2023.100232

OpenUrl availability

Full text

Cite this

@article{b30b3cd1eea9413a80f92ecda0eab90d,

title = "NCOA-RET fusion as a secondary resistance mechanism to osimertinib in complex EGFR-mutated lung adenocarcinoma: Case report and review of literature",

keywords = "Drug-resistance, EGFR-TKI, NSCLC, Osimertinib, RET fusion",

author = "Romagnolo, {Alberto P.} and Christopher Hino and Saied Mirshahidi and Kristina Chase and Hamid Mirshahidi",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = jun,

doi = "10.1016/j.cpccr.2023.100232",

language = "English",

volume = "10",

journal = "Current Problems in Cancer: Case Reports",

issn = "2666-6219",

}

TY - JOUR

T1 - NCOA-RET fusion as a secondary resistance mechanism to osimertinib in complex EGFR-mutated lung adenocarcinoma

T2 - Case report and review of literature

AU - Romagnolo, Alberto P.

AU - Hino, Christopher

AU - Mirshahidi, Saied

AU - Chase, Kristina

AU - Mirshahidi, Hamid

PY - 2023/6

Y1 - 2023/6

KW - Drug-resistance

KW - EGFR-TKI

KW - NSCLC

KW - Osimertinib

KW - RET fusion

UR - http://www.scopus.com/inward/record.url?scp=85152739737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152739737&partnerID=8YFLogxK

U2 - 10.1016/j.cpccr.2023.100232

DO - 10.1016/j.cpccr.2023.100232

M3 - Article

AN - SCOPUS:85152739737

SN - 2666-6219

VL - 10

JO - Current Problems in Cancer: Case Reports

JF - Current Problems in Cancer: Case Reports

M1 - 100232

ER -

NCOA-RET fusion as a secondary resistance mechanism to osimertinib in complex EGFR-mutated lung adenocarcinoma: Case report and review of literature

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this